Seeking Alpha

Merrimack Pharmaceuticals (MACK): Q3 EPS of -$0.25 beats by $0.01. Revenue of $11.3M (+31% Y/Y)...

Merrimack Pharmaceuticals (MACK): Q3 EPS of -$0.25 beats by $0.01. Revenue of $11.3M (+31% Y/Y) beats by $1.2M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)